Laparoscopic surgery for advanced ovarian cancer after chemo
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial tests if laparoscopic surgery after 3-4 cycles of chemotherapy can help people with advanced epithelial ovarian cancer. It's for those whose tumors have shrunk enough after chemo and who are healthy enough for surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have advanced (stage III or IV) epithelial ovarian cancer.
- Your tumor must have shrunk at least partially after 3-4 rounds of chemotherapy, as seen on a PET-CT scan.
- Your CA-125 blood level must be under 200.
- You must be in good overall health (ECOG score 0-2) and have no major medical problems that would make surgery risky (like heart or lung issues).
- You must not have fluid buildup in your belly or chest that won't go away after chemo.
- Your cancer must be removable by surgery (no large liver tumors, lymph nodes above the kidneys, or disease spread above the diaphragm).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether doing surgery with small incisions (minimally invasive) instead of a large cut is safe and effective for advanced ovarian cancer after chemo. It may mean a faster recovery while still removing the cancer.
This trial tests giving chemotherapy directly into the abdomen (intraperitoneal) after optimal surgery for advanced ovarian cancer. It aims to see if this approach is safe and effective for women who have already received 3-4 cycles of chemotherapy before surgery.
This trial studies whether doing surgery using smaller incisions after chemotherapy works as well as a more traditional approach for certain people with stage IIIC–IV ovarian, fallopian tube, or primary peritoneal cancer. It may help reduce surgical trauma while aiming for effective tumor removal.
This trial tests whether removing recurrent ovarian cancer with surgery after chemotherapy can help patients live longer. It is for women whose cancer came back at least 6 months after finishing platinum-based chemo and who responded to chemo after the recurrence.
This trial is for people with recurrent ovarian cancer whose disease came back more than 6 months after platinum chemo. It tests whether removing the recurrent tumor with surgery (after more chemo) can help—even if surgery wasn't an option before.
This trial studies whether an additional treatment after surgery can help people with early-stage epithelial ovarian cancer live longer and stay well for more time. It is meant for patients who had a detailed staging operation and are able to start treatment within 8 weeks.
Hear when a new Ovarian Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.